More than half of the

Global Fortune 500

companies use BMIs
Reports to inform their
strategic planning and
business development
in emerging and
frontier markets. Join
them today, with the
protection of our 100%
Money Back Guarantee!
(See back page for details).
Jonathan Feroze, Publisher,
Business Monitor International
Just published
30 Reports covering
Middle East & Africas
top Pharmaceuticals
and Healthcare
markets:
Q
Algeria
Q
Angola
Q
Bahrain
Q
Botswana
Q
Cameroon
Q
Cte dIvoire
Q
Egypt
Q
Gabon
Q
Ghana
Q
Iran
Q
Iraq
Q
Israel
Q
Jordan
Q
Kenya
Q
Kuwait
Q
Lebanon
Q
Morocco
Q
Mozambique
Q
Namibia
Q
Nigeria
Q
Oman
Q
Qatar
Q
Saudi Arabia
Q
South Africa
Q
Sudan
Q
Tanzania
Q
UAE
Q
Uganda
Q
Zambia
Q
Zimbabwe
www.businessmonitor.com/dm/pharma/middleeastafrica
If you have a Promotion
Code please use it
when ordering single
or multiple Reports to
receive your discount.
Full price for a single Report is
US$1,295 / 985 / 810
Just Published
M
A
L
A
Y
S
IA
OIL AND GAS REPORT
PUBLISHED BY BUSINESS MONITOR INTERNATIONAL
INDIA
OIL AND GAS REPORT
PUBLISHED BY BUSINESS MONITOR INTERNATIONAL
PAKISTAN
OIL AND GAS REPORT
PUBLISHED BY BUSINESS MONITOR INTERNATIONAL
N
IG
E
R
IA
PH
AR
M
AC
EU
TIC
ALS & H
EALTH
C
AR
E R
EPO
RT
PUBLISHED BY BUSINESS M
ONITOR INTERNATIONAL
G
H
A
N
A
PHARMACEUTICALS & HEALTHCARE REPORT
PUBLISHED BY BUSINESS MONITOR INTERNATIONAL
JORDAN
PHARMACEUTICALS & HEALTHCARE REPORT
PUBLISHED BY BUSINESS MONITOR INTERNATIONAL
KUWAIT
PHARMACEUTICALS & HEALTHCARE REPORT
PUBLISHED BY BUSINESS MONITOR INTERNATIONAL
Middle East & Africa
Pharmaceuticals &
Healthcare Reports
Q
Benet from the latest
market opportunities
Q
Protect your company
against future risks
Q
Prepare for the
impact of market
changes
Q
Know what your
competitors
are planning
Business Monitor Internationals Pharmaceuticals & Healthcare Reports,
incorporating specialist insight from Espicom Business Intelligence, provide
expert assessments on the outlook for 30 key markets across the Middle
East & Africa. They reveal crucial opportunities for your company and give
you invaluable insight to improve your operations and investments.
Your choice of 30 Country Reports
With these Reports you will be better prepared for unexpected market
changes. You get insight on a markets outlook, in-depth assessment
of trends, opportunities and risks, and key competitive intelligence.
Key Benets:

Latest opportunities
to prot from
Independent forecasts reveal
where the next opportunities
lie. So whether you are looking
to newly invest or build on your
companys existing operations
you will know where to focus
your attention for key growth.

Risk warnings to
protect your company
Identify threats to your plans
via our easy-to-use Risk
Reward Ratings tables. They
compare each country in the
region by operational, market
and country-specic risks
and rewards.

Crucial market
developments
to act on
Evaluate the commercial
potential of regulatory and
reimbursement developments
to your business, as well as
the impact of investment
dynamics, new research and
broader demographic and
disease trends.

Competitor analysis
to know who you are
up against
Understand the activities,
strategy and market position
of your competitors, partners
and clients to best position your
company using our Company
Proles (inc. SWOTs, KPIs,
latest activity) and Competitive
Landscape Tables.
Leading companies who rely on our analysis:
Benchmark Your Strategy
against BMIs market forecasts
Use BMIs forecasts to ensure your strategy
for growth aligns with the direction the market
is taking.
Our forecasting model has been developed
by in-house economists and pharmaceuticals
and healthcare analysts. It identies statistical
correlations between industry data and
country-specic economic, nancial and
demographic indicators giving you reliable,
stress-tested industry forecasts and growth
assumptions.
The methodology is proven to complement
other forecasting models that are also driven
by industry- or company-specic variables,
so you can double check your current market
intelligence and ll in any gaps.
Understand The Risks
of the market to your business
Know what could threaten your operations and
avoid the dangers.
Industry Risk Reward Ratings: Country-
comparative Risk Reward Ratings help you
assess the suitability of a market for your
operations. They give you a quantied,
independent assessment of the dangers and
opportunities. The ratings combine in-depth
knowledge of competitive pressures and
market forecasts, with unrivalled analysis of
economic, political and operational risks from
BMIs specialist Country Risk team.
Business Environment Assessment: You
receive crucial input when evaluating a markets
potential with our thorough analysis of the
underlying business environment (including an
assessment of operational risk) in the market.
Exploit Emerging Trends
to enhance your business plan
Understand key changes that could support,
strengthen or disrupt your activity in a market.
Our analysts identify the key demographic,
disease, regulatory (inc. pricing) and economic
trends that will shape a markets development
over the coming years. The impact of country,
regional and global trends (including an
analysis of similar developments in peer states)
are evaluated, as are the broader economic,
demographic and political drivers, giving you a
comprehensive view of the changes a market
will undergo.
Analyse Your Competitors,
partners and clients plans
against your own
Know the activities, positioning and strategy
of your competitors, partners and clients to
strengthen your position in the market.
The Reports feature the very latest intelligence
and analysis of all leading national and
multinational companies, giving you:
Company SWOT (Strengths, Weaknesses,
Opportunities, Threats) analysis.
Competitive Intelligence on corporate
strategy, nancial performance, products
and services, ownership, market share and
recent activity (e.g. product developments,
investment, M&A, etc.).
Rankings and Competitive Landscapes
by US$ sales, market share, number of
employees, ownership structure, year
established, expansion and investment
strategies.
This combines to give you a full view of the
competitive landscape you are operating in
to understand and enhance your position.
Abbott Laboratories
Al Bateen Investment Co LLC
AstraZeneca
Bayer AG
Boehringer Ingelheim SA
Cipla Medpro South Africa Limited
Ferring Pharmaceuticals BV
GlaxoSmithKline plc
Janssen
Merck Sharp & Dohme
Novo Nordisk A/S
Pzer Ltd
Sano-aventis
Teva Pharmaceuticals Industries Ltd
Rely on Business Monitor International (BMI) to take
the risk out of your strategic planning, with expert
analysis and forecasts for 30 key Middle East &
African Pharmaceuticals and Healthcare markets.
To access
all this great
content turn
the page to
order
CONTENTS OF THE REPORTS:
Sample Report content
*Company proles are not available for every country. Those
reports instead contain information on the current activities of
prominent companies operating in the market.
Sources
The Pharmaceuticals & Healthcare Reports draw on an extensive network of primary sources, such as multinational
organisations, government departments, industry associations, chambers and company reports, including:
American Chamber of Commerce in Egypt Association of European Self-Medication Industry (AESGP) Iran
Ministry of Health Jordan Association Pharmaceutical of Manufacturers Jordan Food and Drug Administration
Kuwait Ministry of Health Lebanon Ministry of Health Manufacturers Association of Israel (MAoI) Morocco
Ministry of Health Nigeria Ministry of Health Oman Ministry of Health Qatar Statistics Authority Saudi Arabia
Ministry of Health South African Medical Database (SAMED) UN comtrade US Commercial Service USAID -
Assistance For Iraq World Health Organization (WHO)
4 Market Summary
A snapshot of key market characteristics,
including total size of the pharmaceuticals
and healthcare segments, growth drivers,
leading therapeutic areas and the competitive
landscape.
5 Industry Developments
A focus on government healthcare reforms,
epidemiological trends, mergers and
acquisitions, product launches, market
entries, FDI activity, R&D, biotechnology,
clinical trials and supply chain issues.
6 Regulatory Regime
Details of the industry regulatory framework
and key legislation covering the licensing
of new products/services, pricing and
reimbursements, intellectual property, taxation
and advertising, as well as analysis of the
overall regulatory burden.
7 Competitive Landscape
The competitive landscape section provides
comparative company analyses and rankings
by US$ sales and % share of total sales for
the total pharmaceutical sector, as well as the
OTC, generics and distribution sub-sectors.
8 Company Proles*
Examines the competitive positioning and
short- to medium-term business strategies of
key industry players. Strategy is examined within
the context of BMIs industry forecasts, our
macroeconomic views and our understanding
of the wider competitive landscape to generate
Company SWOT analyses. The latest nancial
and operating statistics and key company
developments are also incorporated within the
company proles, enabling a full evaluation of
recent company performance and future growth
prospects.
Our proles give you important
insight on key market players,
including:
Aspen Pharmacare
Bader Sultan & Bros
Exir Pharmaceuticals
GlaxoSmithKline
Gulf Pharmaceutical Industries (Julphar)
Johnson & Johnson
1 BMI Industry View
An at-a-glance perspective on the latest
regulatory developments, key forecast
indicators and major corporate developments,
covering the prescription, OTC and generics
markets. The pharmaceuticals and healthcare
SWOT outlines strategic factors that affect
the basic assumptions underpinning BMIs
forecast analysis, and taken together with
BMIs political, economic and business
environment SWOTs, it gives a complete
overview of market climate.
2 BMI Industry Forecast Scenario
Industry forecasts to end-2018 for all key
indicators, supported by explicit assumptions,
plus analysis of key downside risks to the
main forecasts:
Healthcare: Total healthcare expenditure
(US$bn), healthcare expenditure (% of GDP),
healthcare expenditure per capita (US$),
hospital beds, doctors, and birth & mortality
rates (all per 000 population).
Pharmaceutical market: Drug expenditure
in US$bn, % of GDP and per capita (US$).
Patented drug market: Prescription drug
sales (US$bn & % of total sales), sales broken
down by 14 therapeutic areas (cardiovascular,
anti-infectives etc.).
Generic drug market: Generic product sales
(US$bn), generic sales (% of total sales).
OTC drug market: OTC sales (US$bn & %
of total sales), sales broken down by product
types (analgesics, skin treatments, vitamins
and minerals etc.).
Medical devices: Medical device sales
(US$bn), medical device sales (% of total
healthcare market).
Macroeconomic forecasts: Nominal and
real GDP, % real GDP growth, % private
consumption growth, % industrial output
growth, % consumer price index, % GDP
price deator, exports, imports, trade balance,
current account balance, foreign direct
investment, exchange rate against US$,
government expenditure and external debt.
3 BMIs Pharmaceuticals and
Healthcare Risk Reward Ratings
BMIs Risk Reward Ratings provide investors
(both national and multinational) looking for
opportunities in the region with a clear country-
comparative assessment of the markets risks
and potential rewards. Each of the 30 country
markets are scored using a sophisticated
model that includes more than 40 industry,
economic and demographic data points to
provide a ranking of highest to lowest appeal
to investors, with each ranking explained.
Fax your order to +44 (0) 20 7248 0467
Email your order to sectors@email.businessmonitor.com
Call our Customer Services team on +44 (0) 20 7246 1403 to discuss
your information needs and for special discounts on multi-report orders.
Send your order to:
Business Monitor International
Senator House,
85 Queen Victoria Street,
London, EC4V 4AB, UK
FIVE easy ways to order
Our complete portfolio of Pharmaceuticals & Healthcare Reports covers 96 countries across the globe.
www.businessmonitor.com/dm/pharma/global
On processing your order you will be sent the Report in print by airmail,
along with 3 free PDF quarterly updates over the next 12 months.
For instant access to your Reports simply order online at:
www.businessmonitor.com/dm/pharma/middleeastafrica
To receive your Pharmaceuticals & Healthcare Reports use any of the following ways to order.
And if you have a Promotion Code please use it when ordering to receive your discount
from the full Report price of US$1,295 / 985 / 810.